Litvanya -
Litvanyaca -
SMCA (Valstybinė vaistų kontrolės tarnyba)
sugammadex kalceks
as kalceks - sugamadeksas - injekcinis tirpalas - 100 mg/ml - sugammadex
Avrupa Birliği -
Litvanyaca -
EMA (European Medicines Agency)
bridion
merck sharp & dohme b.v. - sugamadeksas - neuromuskulinė blokada - visi kiti gydomieji produktai - rukuronio arba vekuronio sukeltos nervų ir raumenų blokados pasikeitimas. už peadiatric gyventojų: sugammadex yra tik rekomenduojamas kasdienei atstatymas rocuronium sukeltos blokados vaikams ir paaugliams.
Avrupa Birliği -
Litvanyaca -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulinė blokada - sugamadeksas - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Avrupa Birliği -
Litvanyaca -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulinė blokada - visi kiti gydomieji produktai - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Avrupa Birliği -
Litvanyaca -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulinė blokada - visi kiti gydomieji produktai - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Avrupa Birliği -
Litvanyaca -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulinė blokada - visi kiti gydomieji produktai - rukuronio arba vekuronio sukeltos nervų ir raumenų blokados pasikeitimas. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Avrupa Birliği -
Litvanyaca -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulinė blokada - visi kiti gydomieji produktai - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Litvanya -
Litvanyaca -
SMCA (Valstybinė vaistų kontrolės tarnyba)
zenagam
zenthique limited - sugamadekso natrio druska - injekcinis tirpalas - 100 mg/ml - sugammadex
Litvanya -
Litvanyaca -
SMCA (Valstybinė vaistų kontrolės tarnyba)
rocuronium bromide kalceks
as kalceks - rokuronio bromidas - injekcinis ar infuzinis tirpalas - 10 mg/ml - rocuronium bromide
Litvanya -
Litvanyaca -
SMCA (Valstybinė vaistų kontrolės tarnyba)
esmeron
n.v. organon - rokuronio bromidas - injekcinis ar infuzinis tirpalas - 10 mg/ml - rocuronium bromide